Effects of Once-Daily, Extended-Release Memantine on Individual Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease

被引：0
|
作者：
Tocco, Michael
Hendrix, Suzanne
Miller, Michael L.
Pejovic, Vojislav
Graham, Stephen M.
机构：
来源：
ANNALS OF NEUROLOGY | 2011年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [21] An Open-Label Extension Study Evaluating the Safety and Tolerability of Extended-Release Memantine (Once Daily, 28 Mg) in Patients with Moderate to Severe Alzheimer's Disease
    Alva, Gustavo
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Gutierrez Robledo, Luis Miguel
    Gloger, Sergio
    Xie, Lei
    Jia, Xinwei D.
    Perhach, James L.
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S72 - S73
  • [22] Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease
    Perez Lloret, Santiago
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2221 - 2230
  • [23] Effect of Extended-Release Memantine on Behavioral Domains in Patients with Moderate to Severe Alzheimer's Disease
    Tocco, Michael
    Graham, Stephen M.
    Hsu, Hai-an
    Xie, Lei
    Perhach, James L.
    ANNALS OF NEUROLOGY, 2010, 68 (04) : S49 - S49
  • [24] Cumulative Benefits of Extended-Release Memantine (28 mg, Once Daily) Across Clinical Domains in Patients With Moderate to Severe Alzheimer's Disease: An Area Under the Curve Analysis
    Atri, Alireza
    Tocco, Michael
    Hendrix, Suzanne
    Pejovic, Vojislav
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (03): : S120 - S121
  • [25] Response Across Multiple Outcome Measures in a Randomized Trial of Extended-release Memantine (28 mg, once daily) in Patients with Moderate to Severe Alzheimer's Disease Receiving Donepezil
    Grossberg, George
    Alva, Gustavo
    Hendrix, Suzanne
    Ellison, Noel
    Johnstone, Merrilee R.
    Edwards, John
    NEUROLOGY, 2017, 88
  • [26] Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease
    Bassil, Nazem
    Thaipisuttikul, Papan
    Grossberg, George T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1765 - 1771
  • [27] Pharmacokinetic profile of once-daily cyclobenzaprine extended-release
    Darwish, Mona
    Hellriegel, Edward T.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1425 - 1436
  • [28] Tolerability and efficacy of once-daily galantamine extended-release in patients with mild to moderate AD.
    Corey-Bloom, J
    Yan, B
    Damaraju, CV
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S127 - S127
  • [29] Once-daily extended-release liquid for ADHD approved
    不详
    NURSE PRACTITIONER, 2018, 43 (01): : 56 - 56
  • [30] Extended-Release Memantine (28 mg, Once Daily) and Sustained Behavioral Improvement: Post hoc Responder Analysis From a Randomized Trial in Patients With Moderate to Severe Alzheimer's Disease
    Cummings, Jeffrey L.
    Hendrix, Suzanne
    Miller, Michael
    Pejovic, Vojislav
    Graham, Stephen M.
    Tocco, Michael
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (03): : S130 - S130
12345